Smruthi Organics Limited engages in manufactures and markets active pharmaceutical ingredient (API) products to India, Asia, Africa, the Americas, and internationally. The company's API products, include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, vildagliptin, teneligliptin, and dapagliflozin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; ticagrelor for anti-platelets; and anti - hypertension. It provides drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs. In addition, it is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It exports its products. Smruthi Organics Limited was incorporated in 1989 and is headquartered in Solapur, India.